Page 2 - ப்ரையாரிடீ விமர்சனம் வவுச்சர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates

Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of hawaii at manoaOreola doniniMarburg marburgvirusAxel lehrerTheodore randolphUs congressUniversity of hawaiNational institute of healthSmall business innovation researchNational institute of allergyJohna burns school of medicineSoligenix incDepartment of chemicalDefense threat reduction agencyUniversity of hawaii

Aequus Pharmaceuticals Inc and reVision Therapeutics, Inc in collaboration to develop therapy for Stargardt disease

The agreement allows Aequus the option to acquire the North American commercial rights to REV-0100, reVision’s proprietary Stargardt disease program

New yorkUnited statesPaul fehlnerDoug janzenAequus pharmaceuticalsDrug administrationAequus pharmaceuticals incVision therapeuticsNorth americanPriority review voucherRare pediatric disease drugOrphan drugGood manufacturing practiceWeill cornell medicineNew york citySmall caps

Aequus and reVision to Collaborate on Stargardt Disease Program

Aequus and reVision to Collaborate on Stargardt Disease Program
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesBritish columbiaPaul fehlnerDoug janzenPrnewswire aequus pharmaceuticals incDrug administrationVision therapeutics incCompany annual information formAequus pharmaceuticals incVision therapeuticsNorth americanWeill cornell medicineNew york cityOrphan drugRare pediatric disease drug

Aequus and reVision to Collaborate on Stargardt Disease

Aequus and reVision to Collaborate on Stargardt Disease
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomBritish columbiaPaul fehlnerDoug janzenDrug administrationVision therapeutics incCompany annual information formAequus pharmaceuticals incVision therapeuticsNorth americanWeill cornell medicineNew york cityOrphan drugRare pediatric disease drug

Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.

United statesNew jerseyHellen kimChristopherj schaberUs congressNational institute of allergyPayroll protection programSoligenix incHospital of the university pennsylvaniaDefense threat reduction agencyPrnewswire soligenix incBiomedical advanced researchJersey technology business tax certificate transfer programDevelopment authorityExchange commissionPerelman center